ACTIVE PHARMACEUTICAL INGREDIENTS MARKET ANALYSIS

Active Pharmaceutical Ingredients (API) Market, By Product Type (Low Potent APIs, High Potent APIs), By Molecular Type (Small Molecules, Large Molecules), By Formulation (Oral, Topical, Injectables, Drops), By Application (Diabetes, Oncology, Cardiovascular, CNS, Analgesics, Ophthalmic, Respiratory, Dermatology, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Sep 2023
Code : CMI738
Pages :310
Formats :
Excel and PDF
Industry : Pharmaceutical

Regional Analysis

Global Active Pharmaceutical Ingredients Market - Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global active pharmaceutical ingredients market over the forecast period. The North American market is witnessing a rise in the incidence of chronic diseases, and the government is taking initiatives to develop innovative drugs. The demand for biological API segment in North America is increasing due to the rapid adoption of biological drugs for treating various chronic disorders. For example, according to the Alzheimer’s Association, Alzheimer’s dementia affects approximately 6.2 million people aged 65 and older in the U.S., and it is estimated to increase to 12.7 million by 2050. The growth of this market in the North American region has been propelled by the increase in cases of such chronic disorders.

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa